Skip to main
LGN

Legence Corp (LGN) Stock Forecast & Price Target

Legence Corp (LGN) Analyst Ratings

Based on 17 analyst ratings
Strong Buy
Strong Buy 65%
Buy 29%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Legence is a strong player in the engineering and installation industry, with a focus on technically demanding buildings such as those in the technology, life sciences, healthcare, and education sectors. While fixed-price contracts may pose a risk to margins, Guggenheim Securities has raised their price target due to improved prospects and higher valuations. Sustainable and compliance discussions with clients, strong backlog and revenue outlook, and a history of exceeding expectations in their first quarter results, solidify Legence's potential for continued organic and strategic growth.

Bears say

Legence is well-positioned in the growing technical building services market, but macroeconomic volatility could negatively impact spending and delay projects, dampening revenues. Despite a record backlog, LGN faces risks from long warranty liabilities, technical complexity, intensifying competition, and changing energy efficiency policies, which could all weigh on profitability and shareholder value in the long-term. Additionally, high valuations, input cost inflation, and potential supply chain constraints add to the risks for the company's future earnings and potential growth.

Legence Corp (LGN) has been analyzed by 17 analysts, with a consensus rating of Strong Buy. 65% of analysts recommend a Strong Buy, 29% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Legence Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Legence Corp (LGN) Forecast

Analysts have given Legence Corp (LGN) a Strong Buy based on their latest research and market trends.

According to 17 analysts, Legence Corp (LGN) has a Strong Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $77.97, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $77.97, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Legence Corp (LGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.